| Primary |
| Hiv Infection |
51.9% |
| Pulmonary Tuberculosis |
25.5% |
| Prophylaxis |
9.8% |
| Meningitis Cryptococcal |
3.9% |
| Acquired Immunodeficiency Syndrome |
3.6% |
| Tuberculosis |
2.1% |
| Human Immunodeficiency Virus Transmission |
1.5% |
| Kaposi's Sarcoma |
1.5% |
| Respiratory Tract Infection |
0.3% |
|
| Weight Decreased |
23.5% |
| Death |
11.3% |
| Tuberculosis |
11.3% |
| Immune Reconstitution Syndrome |
6.1% |
| Viral Mutation Identified |
5.2% |
| Vomiting |
5.2% |
| Sepsis |
4.3% |
| Meningitis Cryptococcal |
3.5% |
| Neuropathy Peripheral |
3.5% |
| Rash |
3.5% |
| Cerebrovascular Accident |
2.6% |
| Diarrhoea |
2.6% |
| Mycobacterium Avium Complex Infection |
2.6% |
| Opportunistic Infection |
2.6% |
| Pneumonia |
2.6% |
| Pulmonary Tuberculosis |
2.6% |
| Drug Exposure During Pregnancy |
1.7% |
| Kaposi's Sarcoma |
1.7% |
| Malaria |
1.7% |
| Pancytopenia |
1.7% |
|
| Secondary |
| Hiv Infection |
53.4% |
| Acquired Immunodeficiency Syndrome |
15.9% |
| Prophylaxis |
10.2% |
| Human Immunodeficiency Virus Transmission |
9.1% |
| Kaposi's Sarcoma Aids Related |
5.7% |
| Kaposi's Sarcoma |
4.5% |
| Respiratory Tract Infection |
1.1% |
|
| Death |
16.2% |
| Drug Exposure During Pregnancy |
10.8% |
| Immune Reconstitution Syndrome |
8.1% |
| Toxic Epidermal Necrolysis |
8.1% |
| Tuberculosis |
8.1% |
| Progressive Multifocal Leukoencephalopathy |
5.4% |
| Vaginal Candidiasis |
5.4% |
| Viral Load Increased |
5.4% |
| Central Nervous System Lymphoma |
2.7% |
| Cytomegalovirus Infection |
2.7% |
| Diarrhoea |
2.7% |
| Encephalitis |
2.7% |
| Herpes Zoster |
2.7% |
| Lacunar Infarction |
2.7% |
| Meningitis Cryptococcal |
2.7% |
| Mycobacterial Infection |
2.7% |
| Pneumocystis Jiroveci Pneumonia |
2.7% |
| Rash |
2.7% |
| Spinal Cord Compression |
2.7% |
| Subarachnoid Haemorrhage |
2.7% |
|
| Concomitant |
| Hiv Infection |
66.7% |
| Diabetes Mellitus |
33.3% |
|
| Diabetes Mellitus |
50.0% |
| Pancytopenia |
50.0% |
|
